Hepatitis C virus infection and risk of gallstones: A meta-analysis

Karn Wijarnpreecha1, Charat Thongprayoon1, Panadeekarn Panjawatanan2

  • 1Department of Internal Medicine, Bassett Medical Center, Cooperstown, NY, USA.

Insights

Hepatitis C virus (HCV) infection significantly increases gallstone risk. This meta-analysis confirms a higher prevalence of gallstones in HCV-infected individuals, highlighting a need for clinical attention to this association.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Epidemiology

Background:

  • Gallstones are common hepatobiliary diseases.
  • Hepatitis C virus (HCV) infection may be linked to increased gallstone risk, but evidence is inconclusive.
  • This meta-analysis synthesizes existing data on the HCV-gallstone relationship.

Purpose of the Study:

  • To quantitatively assess the association between hepatitis C virus infection and gallstone risk.
  • To summarize the available epidemiological evidence on this relationship.

Main Methods:

  • A comprehensive literature search was conducted in MEDLINE and EMBASE databases up to May 2016.
  • Included studies reported risk estimates (RR, OR, HR) comparing gallstone risk in HCV-infected vs. non-infected subjects.
  • Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated using random-effects modeling.

Main Results:

  • Eleven studies were included in the meta-analysis.
  • HCV-infected patients showed a significantly increased risk of gallstones (pooled OR = 1.83, 95% CI: 1.35-2.48).
  • Subgroup analyses revealed increased risk in both males (OR = 2.07) and females (OR = 3.00).

Conclusions:

  • Hepatitis C virus infection is associated with a significantly elevated risk of gallstones.
  • Further research is needed to understand the clinical implications and management of gallstones in HCV-infected patients.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212
Gallbladder01:17

Gallbladder

The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
2.4K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
258
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
634